Cargando…

MS-DAP Platform for Downstream Data Analysis of Label-Free Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased Sensitivity in Analysis of Alzheimer’s Biomarker Data

[Image: see text] In the rapidly moving proteomics field, a diverse patchwork of data analysis pipelines and algorithms for data normalization and differential expression analysis is used by the community. We generated a mass spectrometry downstream analysis pipeline (MS-DAP) that integrates both po...

Descripción completa

Detalles Bibliográficos
Autores principales: Koopmans, Frank, Li, Ka Wan, Klaassen, Remco V., Smit, August B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903323/
https://www.ncbi.nlm.nih.gov/pubmed/36541440
http://dx.doi.org/10.1021/acs.jproteome.2c00513
_version_ 1784883448753684480
author Koopmans, Frank
Li, Ka Wan
Klaassen, Remco V.
Smit, August B.
author_facet Koopmans, Frank
Li, Ka Wan
Klaassen, Remco V.
Smit, August B.
author_sort Koopmans, Frank
collection PubMed
description [Image: see text] In the rapidly moving proteomics field, a diverse patchwork of data analysis pipelines and algorithms for data normalization and differential expression analysis is used by the community. We generated a mass spectrometry downstream analysis pipeline (MS-DAP) that integrates both popular and recently developed algorithms for normalization and statistical analyses. Additional algorithms can be easily added in the future as plugins. MS-DAP is open-source and facilitates transparent and reproducible proteome science by generating extensive data visualizations and quality reporting, provided as standardized PDF reports. Second, we performed a systematic evaluation of methods for normalization and statistical analysis on a large variety of data sets, including additional data generated in this study, which revealed key differences. Commonly used approaches for differential testing based on moderated t-statistics were consistently outperformed by more recent statistical models, all integrated in MS-DAP. Third, we introduced a novel normalization algorithm that rescues deficiencies observed in commonly used normalization methods. Finally, we used the MS-DAP platform to reanalyze a recently published large-scale proteomics data set of CSF from AD patients. This revealed increased sensitivity, resulting in additional significant target proteins which improved overlap with results reported in related studies and includes a large set of new potential AD biomarkers in addition to previously reported.
format Online
Article
Text
id pubmed-9903323
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-99033232023-02-08 MS-DAP Platform for Downstream Data Analysis of Label-Free Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased Sensitivity in Analysis of Alzheimer’s Biomarker Data Koopmans, Frank Li, Ka Wan Klaassen, Remco V. Smit, August B. J Proteome Res [Image: see text] In the rapidly moving proteomics field, a diverse patchwork of data analysis pipelines and algorithms for data normalization and differential expression analysis is used by the community. We generated a mass spectrometry downstream analysis pipeline (MS-DAP) that integrates both popular and recently developed algorithms for normalization and statistical analyses. Additional algorithms can be easily added in the future as plugins. MS-DAP is open-source and facilitates transparent and reproducible proteome science by generating extensive data visualizations and quality reporting, provided as standardized PDF reports. Second, we performed a systematic evaluation of methods for normalization and statistical analysis on a large variety of data sets, including additional data generated in this study, which revealed key differences. Commonly used approaches for differential testing based on moderated t-statistics were consistently outperformed by more recent statistical models, all integrated in MS-DAP. Third, we introduced a novel normalization algorithm that rescues deficiencies observed in commonly used normalization methods. Finally, we used the MS-DAP platform to reanalyze a recently published large-scale proteomics data set of CSF from AD patients. This revealed increased sensitivity, resulting in additional significant target proteins which improved overlap with results reported in related studies and includes a large set of new potential AD biomarkers in addition to previously reported. American Chemical Society 2022-12-21 /pmc/articles/PMC9903323/ /pubmed/36541440 http://dx.doi.org/10.1021/acs.jproteome.2c00513 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Koopmans, Frank
Li, Ka Wan
Klaassen, Remco V.
Smit, August B.
MS-DAP Platform for Downstream Data Analysis of Label-Free Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased Sensitivity in Analysis of Alzheimer’s Biomarker Data
title MS-DAP Platform for Downstream Data Analysis of Label-Free Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased Sensitivity in Analysis of Alzheimer’s Biomarker Data
title_full MS-DAP Platform for Downstream Data Analysis of Label-Free Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased Sensitivity in Analysis of Alzheimer’s Biomarker Data
title_fullStr MS-DAP Platform for Downstream Data Analysis of Label-Free Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased Sensitivity in Analysis of Alzheimer’s Biomarker Data
title_full_unstemmed MS-DAP Platform for Downstream Data Analysis of Label-Free Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased Sensitivity in Analysis of Alzheimer’s Biomarker Data
title_short MS-DAP Platform for Downstream Data Analysis of Label-Free Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased Sensitivity in Analysis of Alzheimer’s Biomarker Data
title_sort ms-dap platform for downstream data analysis of label-free proteomics uncovers optimal workflows in benchmark data sets and increased sensitivity in analysis of alzheimer’s biomarker data
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903323/
https://www.ncbi.nlm.nih.gov/pubmed/36541440
http://dx.doi.org/10.1021/acs.jproteome.2c00513
work_keys_str_mv AT koopmansfrank msdapplatformfordownstreamdataanalysisoflabelfreeproteomicsuncoversoptimalworkflowsinbenchmarkdatasetsandincreasedsensitivityinanalysisofalzheimersbiomarkerdata
AT likawan msdapplatformfordownstreamdataanalysisoflabelfreeproteomicsuncoversoptimalworkflowsinbenchmarkdatasetsandincreasedsensitivityinanalysisofalzheimersbiomarkerdata
AT klaassenremcov msdapplatformfordownstreamdataanalysisoflabelfreeproteomicsuncoversoptimalworkflowsinbenchmarkdatasetsandincreasedsensitivityinanalysisofalzheimersbiomarkerdata
AT smitaugustb msdapplatformfordownstreamdataanalysisoflabelfreeproteomicsuncoversoptimalworkflowsinbenchmarkdatasetsandincreasedsensitivityinanalysisofalzheimersbiomarkerdata